Clinical Trials in Michigan

Showing 1061-1080 of 16,154 trials

ETNA-MS Device Validation Study

NCT06256731

The overarching goal of this research protocol is to validate the effectiveness of Innodem's ETNA-MS device in informing clinicians on the disability status of Multiple Sclerosis (MS) patients. Effectiveness of the device will be assessed by the level of agreement between the EDSS estimated by the device and the actual scores measured by the neurologist in-person assessments.

Multiple Sclerosis

Innodem Neurosciences60 participantsStarted Dec 2023

Phoenix, Arizona, United States • Farmington Hills, Michigan, United States • Owosso, Michigan, United States +2 more locations

Active Not Recruiting42 miles

ADAPT - A Patient Registry of the Real-world Use of Orenitram®

NCT03045029

This prospective, observational, multicenter, patient registry will follow patients who are receiving treatment with Orenitram for the treatment of PAH for up to 78 weeks from Orenitram initiation

Pulmonary Arterial Hypertension

United Therapeutics300 participantsStarted Jul 2017

Fresno, California, United States • Los Angeles, California, United States • San Juan Capistrano, California, United States +38 more locations

ETNA-MS Device Validation Study

ADAPT - A Patient Registry of the Real-world Use of Orenitram®

Find Trials by Condition in Michigan

A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUGANO) Primary Efficacy Will be Determined at Week 56

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)

Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE (BOLD)

The Lilac Device Trial

Treatment Free Remission After Combination Therapy With Ruxolitinib Plus Tyrosine Kinase Inhibitors

Neonatal Phase 1 Valacyclovir Study

Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies

Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma

A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism Spectrum Disorder

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

To Evaluate the Performance of the CORI™ KNEE TENSIONER as an Accessory to the CORI™ Surgical System.

Astroscape: A Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients With TSC or FCD Type II

Phase 2b Safety and Efficacy Study of CGB-500 Topical Ointment With 0.5% and 1% Tofacitnib for Treatment of Atopic Dermatitis

A Phase 3 Study to Evaluate the Safety and Tolerability of L606 in Subjects With PAH or PH-ILD

A Study to Assess the Effects of Zigakibart on IgA Nephropathy.

MISHA Post-Market Clinical Study

Development of Digital Biomarkers in Multiple Sclerosis: Validation Study 2